GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oragenics Inc (AMEX:OGEN) » Definitions » E10

OGEN (Oragenics) E10 : $-69.21 (As of Sep. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Oragenics E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Oragenics's adjusted earnings per share data for the three months ended in Sep. 2024 was $-0.380. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-69.21 for the trailing ten years ended in Sep. 2024.

During the past 3 years, the average E10 Growth Rate was 33.20% per year. During the past 5 years, the average E10 Growth Rate was 30.80% per year. During the past 10 years, the average E10 Growth Rate was 26.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Oragenics was 33.20% per year. The lowest was 16.50% per year. And the median was 24.50% per year.

As of today (2025-03-05), Oragenics's current stock price is $0.2699. Oragenics's E10 for the quarter that ended in Sep. 2024 was $-69.21. Oragenics's Shiller PE Ratio of today is .


Oragenics E10 Historical Data

The historical data trend for Oragenics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oragenics E10 Chart

Oragenics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -353.76 -259.55 -178.88 -117.27 -77.25

Oragenics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -84.10 -77.25 -74.76 -71.30 -69.21

Competitive Comparison of Oragenics's E10

For the Biotechnology subindustry, Oragenics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oragenics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oragenics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Oragenics's Shiller PE Ratio falls into.



Oragenics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Oragenics's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-0.38/133.0289*133.0289
=-0.380

Current CPI (Sep. 2024) = 133.0289.

Oragenics Quarterly Data

per share eps CPI Adj_EPS
201412 -18.000 99.070 -24.170
201503 -24.000 99.621 -32.048
201506 -102.000 100.684 -134.768
201509 -30.000 100.392 -39.753
201512 -36.000 99.792 -47.990
201603 -30.000 100.470 -39.722
201606 -6.000 101.688 -7.849
201609 -24.000 101.861 -31.344
201612 -34.200 101.863 -44.664
201703 -24.000 102.862 -31.039
201706 -15.000 103.349 -19.308
201709 -25.200 104.136 -32.192
201712 -18.000 104.011 -23.022
201803 -25.200 105.290 -31.839
201806 -22.800 106.317 -28.529
201809 -21.000 106.507 -26.229
201812 -5.617 105.998 -7.049
201903 -6.600 107.251 -8.186
201906 -6.000 108.070 -7.386
201909 -4.800 108.329 -5.894
201912 -4.800 108.420 -5.889
202003 -6.600 108.902 -8.062
202006 -14.400 108.767 -17.612
202009 -4.800 109.815 -5.815
202012 -3.000 109.897 -3.631
202103 -3.000 111.754 -3.571
202106 -1.800 114.631 -2.089
202109 -2.400 115.734 -2.759
202112 -0.890 117.630 -1.007
202203 -2.290 121.301 -2.511
202206 -1.850 125.017 -1.969
202209 -1.990 125.227 -2.114
202212 -0.900 125.222 -0.956
202303 -1.410 127.348 -1.473
202306 -1.510 128.729 -1.560
202309 -0.850 129.860 -0.871
202312 -5.480 129.419 -5.633
202403 -0.700 131.776 -0.707
202406 -0.510 132.554 -0.512
202409 -0.380 133.029 -0.380

Add all the adjusted EPS together and divide 10 will get our e10.


Oragenics  (AMEX:OGEN) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Oragenics E10 Related Terms

Thank you for viewing the detailed overview of Oragenics's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Oragenics Business Description

Traded in Other Exchanges
Address
1990 Main Street, Suite 750, Tampa, FL, USA, 34236
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.
Executives
Alan W Dunton director VICURON PHARMACEUTICALS INC, 455 S GULPH ROAD SUITE 305, KING OF PRUSSIA PA 19406
Fred Telling director 501 ELLIOTT AVE. W., SUITE 400, SEATTLE WA 98119
John P Gandolfo director 62 TERRACE ROAD, WAYNE NJ 07470
Cassidy Bruce A. Sr. director C/O LOOP MEDIA, 700 N CENTRAL AVENUE, SUITE 430, GLENDALE CA 91203
Janet Huffman officer: CFO, Secretary and Treasurer 5317 FRUITVILLE RD SUITE 6, SARASOTA FL 34232
Robert C Koski director, 10 percent owner 1500 W UNIVERSITY PARKWAY, SARASOTA FL 34243
Michael O'keefe Sullivan officer: CFO, Secretary and Treasurer 3000 BAYPORT DRIVE, SUITE 685, TAMPA FL 33607
Joseph Hernandez 10 percent owner C/O MICROLIN BIO, INC., NEW YORK NY 10022
Kimberly M Murphy director 101 EAST KENNEDY BLVD., SUITE 2800, TAMPA FL 33602
Koski Family Lp 10 percent owner 1500 W UNIVERSITY PARKWAY, SARASOTA FL 34243
Randal J Kirk 10 percent owner 1881 GROVE AVENUE, RADFORD VA 24141
Alan Joslyn director, officer: CEO and President 39 OLD RIDGEBURY ROAD, DANBURY CT 06810
Charles L Pope director 4902 EISENHOWER BOULEVARD, TAMPA FL 33634
Christine L Koski director, 10 percent owner 1500 WEST UNIVERSITY PARKWAY, SARASOTA FL 34243
Thomas L Koski 10 percent owner

Oragenics Headlines

From GuruFocus